The Microbiological Testing of Water Market is currently valued at USD 1.6 billion in 2022 and is projected to exhibit a robust CAGR of 7.4% to reach USD 2.3 billion by 2027.
Drivers of Market Growth
Consumer awareness regarding the importance of safe and bacteria-free drinking water, coupled with an increase in the demand for water free of contaminants and chemicals, are the primary factors propelling the market's growth. Industries such as pharmaceuticals, biopharmaceuticals, and food extensively employ water testing to ensure the quality of drinking and industrial water. The rise in waterborne diseases like typhoid, dysentery, and cholera also significantly contributes to market expansion.
Key Regional Trends
North America is expected to dominate the Microbiological testing of water market during the forecast period. The region has witnessed several waterborne disease outbreaks, including cryptosporidiosis and giardiasis, due to protozoan contamination. Research from the National Center for Biotechnology Information (NCBI) estimates that waterborne diseases affect a significant number of people in the US each year, leading to thousands of deaths. Factors such as heavy rains, floods, inadequate water treatment, and pathogen proliferation in water reservoirs contribute to these contaminations.
Asia Pacific is poised to achieve the highest Compound Annual Growth Rate (CAGR) in the Microbiological testing of water market. Increased awareness of microbiological water contaminants and their health implications is driving demand in the region. The need for packaged drinking water has spurred the growth of unauthorized companies drawing water from unregulated sources, necessitating microbiological water testing. Leading companies like Agilent Corporation, Shimadzu Corporation, and Thermo Fisher Scientific are providing testing solutions to Asian countries, particularly China.
Key Market Players
Prominent players in the market include 3M, Thermo Fisher Scientific Inc., Danaher Corporation, Döhler Group, Agilent Technologies, Inc., Shimadzu Corporation, Merck, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., IDEXX Laboratories, Inc., Avantor Inc., Hardy Diagnostics, LaMotte Company, Accepta Ltd, and General Laboratory Products. These companies are actively expanding production facilities, launching innovative products, conducting extensive research and development, expanding geographically, and making strategic acquisitions to enhance their market presence and supply chain influence.